Skip to main content
Fig. 6 | Arthritis Research & Therapy

Fig. 6

From: Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis

Fig. 6

Effect of oral PUFA supplementation on RA disease activity by dosage (> or < 2 g/day). Data are standardized mean difference (SMD) (95% CI). VAS visual analog scale, DAS28 Disease Activity Score in 28 joints, ESR erythrocyte sedimentation rate, CRP C-reactive protein, HAQ Health Assessment Questionnaire

Back to article page